Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Cyclo Therapeutics Q2 EPS $(0.21) Misses $(0.16) Estimate, Sales $123.10K Miss $267.50K Estimate

Author: Benzinga Newsdesk | August 15, 2024 09:03am

Cyclo Therapeutics (NASDAQ:CYTH) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.16) by 31.25 percent. This is a 36.36 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $123.10 thousand which missed the analyst consensus estimate of $267.50 thousand by 53.98 percent. This is a 5.11 percent increase over sales of $117.12 thousand the same period last year.

Posted In: CYTH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist